For adults with relapsing forms of Multiple Sclerosis (MS). TYSABRI® (natalizumab) increases the risk of PML. When starting and continuing treatment with TYSABRI, it is important that you discuss with your doctor whether the expected benefit of TYSABRI is enough to outweigh this risk. See TYSABRI Risk Information.
Know More About TYSABRI
Sign up to receive the latest information on TYSABRI and relapsing multiple sclerosis treatments.